- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 5/14 - Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
Patent holdings for IPC class A61P 5/14
Total number of patents in this class: 326
10-year publication summary
|
6
|
5
|
14
|
20
|
14
|
23
|
21
|
17
|
24
|
9
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Madrigal Pharmaceuticals, Inc. | 83 |
13 |
| The University of Chicago | 1413 |
7 |
| Altergon S.A. | 114 |
6 |
| Osaka University | 3379 |
6 |
| University of Miami | 842 |
6 |
| Prizm, LLC | 10 |
6 |
| Hoffmann-La Roche Inc. | 3439 |
5 |
| Metabasis Therapeutics, Inc. | 40 |
5 |
| Mochida Pharmaceutical Co., Ltd. | 338 |
5 |
| The University of Tokyo | 4189 |
5 |
| Terns, Inc. | 28 |
5 |
| Autobahn Therapeutics, Inc. | 41 |
5 |
| Daiichi Sankyo Company, Limited | 1877 |
4 |
| Dainippon Sumitomo Pharma Co., Ltd. | 194 |
4 |
| Kissei Pharmaceutical Co., Ltd. | 184 |
4 |
| Viking Therapeutics, Inc. | 52 |
4 |
| KPC Pharmaceuticals, Inc. | 25 |
4 |
| Aligos Therapeutics, Inc. | 157 |
4 |
| Amgen Inc. | 4076 |
3 |
| F. Hoffmann-la Roche Ltd. | 16 |
3 |
| Other owners | 222 |